1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

13 May 2020
Admin
News Article

Themis Collaborates With Abl Europe In France On The Production Of Its Sars Cov-2 Vaccine Candidate

Themis , A Biopharmaceutical Company With Clinical Development Programs Focused On Immunomodulation Therapies For Infectious Diseases And Cancer , And Abl Europe ( Abl ), Global Contract Development And Manufacturing Organization ( Cdmo ), Contract Research Institute ( Cro) And Subsidiary Of The French Biotechnology Group Institut MÉRieux, Announced Today That Abl Will Produce A Themis Vaccine Candidate In Preparation For Planned Clinical Trials. The Vaccine Is Developed Using A Measles Virus-Based Vaccine Platform, Which Is Licensed Exclusively To Themis By The World-Famous Pasteur Institute In Paris .Dr. Erich Tauber , Ceo Of Themis , Commented: &Ldquo;The Main Reasons Why We Decided To Work With Abl Europe Are Based On Our Previous Experience With The Company And Its Virological Expertise. Abl Has A Significant Advantage When It Comes To Fast Production. This Means That We Can Start Our Clinical Trials Quickly. "Themis Recently Announced That It Is Actively Working With The Pasteur Institute, The Center For Vaccine Research At The University Of Pittsburgh And The Coalition For Epidemic Preparedness Innovations (Cepi) To Develop A Covid-19 Vaccine Candidate. To Date, Cepi Has Invested $ 4.9 Million In This Vaccine Development. Abl Was Selected By Themis As The Manufacturer And Supplier Of The Covid-19 Vaccine Candidate To Be Used For Clinical Trials.&Ldquo;We Consider It A Privilege To Be Able To Work With Themis In The Global Fight Against The Covid-19 Pandemic. In This Specific Situation, We At Abl Will Use Our Know-How To Quickly Bring A Promising Vaccine Candidate Into Clinical Trials, "Said Dr. Patrick Mahieux , Managing Director Of Abl Europe.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!